Interest of real-time PCR Xpert MRSA/SA on GeneXpert® DX System in the investigation of staphylococcal bacteremia;Inté rět de la PCR temps ré el Cepheid Xpert SAMR/SA sur GeneXpert1 DX Systemdans la prise en charge de la bacté riémie ástaphylocoque

Pathologie Biologie

Volumn 59, Issue 2, 2011, Pages 67-72

  Scanvic, A ^a   Courdavault, L ^a   Sollet, J P ^a   Le Turdu, F ^a  

^a CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

Coagulase negative staphylococci; Inappropriate antibiotic therapy; Real time PCR; Staphylococcal bloodstream infection; Staphylococcus aureus

Indexed keywords

BETA LACTAM ANTIBIOTIC; METICILLIN; ANTIINFECTIVE AGENT; COAGULASE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM DETECTION; BLOOD CULTURE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DIAGNOSTIC ACCURACY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; ADOLESCENT; ADULT; AGED; BACTEREMIA; BLOOD; CHILD; CLINICAL TRIAL; COMPUTER SYSTEM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFANT; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; NEWBORN; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; CHILD; CHILD, PRESCHOOL; COAGULASE; COMPUTER SYSTEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 79953169831     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2010.07.016     Document Type: Article

References (31)

1. Porcheret H., Barraud D., Bingen M., Rabenja T., Costa Y., Estève V., et al. Community and noncommunity-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Île-de-France microbiologists network. Pathol Biol 2010, 58:7-14.
2. Fluit A.C., Jones M.E., Schmitz F.J., Acar J., Gupta R., Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 2000, 30:454-460.
3. Unal S., Masterton R., Goossens H. Bacteraemia in Europe - antimicrobial susceptibility data from the Mystic surveillance programme. Int J Antimicrob Agents 2004, 23:155-163.
4. EARSS Annual Report 2008, disponible sur http://www.ecdc.europa.eu/.
5. Van Hal S.J., Frostis V., Miyakis S., Marriott D., Harkness J. Prevalence and significance of coagulase-negative staphylococci isolated from blood cultures in a tertiary hospital. Scand J Infect Dis 2008, 40:551-554.
6. Naber C.K. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis 2009, 48(Suppl. 4):231-237.
7. Carnicer-Pont D., Bailey K.A., Mason B.W., Walker A.M., Evans M.R., Salmon R.L. Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control study. Epidemiol Infect 2006, 134:1167-1173.
8. Souvenir D., Anderson D.E., Palpant S., Mroch H., Askin S., Anderson J., et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol 1998, 36:1923-1926.
9. Bates D.W., Goldman L., Lee T.H. Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA 1991, 265:365-369.
10. Montecalvo M.A., Horowitz H., Gedris C., Carbonaro C., Tenover F.C., Issah A., et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994, 38:1363-1367.
11. Rice B. Antimicrobial pressure and the emergence and spread of multiresistant enterococci. Postgrad Med 2001, 109(Suppl. 2):22-31.
12. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
13. Lodise T.P., McKinnon P.S., Swiderski L., Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36:1418-1423.
14. Hall K.K., Lyman J.A. Updated review of blood culture contamination. Clin Microbiol Rev 2006, 19:788-802.
15. Gröbner S., Dion M., Plante M., Kempf V.A. Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottles. J Clin Microbiol 2009, 47:1689-1694.
16. Wolk D.M., Struelens M.J., Pancholi P., Davis T., Della-Latta P., Fuller D., et al. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol 2009, 47:823-826.
17. Ruimy R., Dos-Santos M., Raskine L., Bert F., Masson R., Elbaz S., et al. Accuracy and potential usefulness of triplex real-time PCR for improving antibiotic treatment of patients with blood cultures showing clustered Gram-positive cocci on direct smears. J Clin Microbiol 2008, 46:2045-2051.
18. Paule S.M., Pasquariello A.C., Thomson R.B., Kaul K.L., Peterson L.R. Real-time PCR can rapidly detect methicillin-susceptible and methicillin-resistant Staphylococcus aureus directly from positive blood culture bottles. Am J Clin Pathol 2005, 124:404-407.
19. Maes N., Magdalena J., Rottiers S., De Gheldre Y., Struelens M.J. Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures. J Clin Microbiol 2002, 40:1514-1517.
20. Comité de l'antibiogramme de la Société française de microbiologie, disponible sur http://www.sfm.asso.fr/.
21. Mitchell D.H., Howden B.P. Diagnosis and management of Staphylococcus aureus bacteraemia. Intern Med J 2005, 35(Suppl. 2):S17-S24.
22. Fowler V.G., Olsen M.K., Corey G.R., Woods C.W., Cabell C.H., Reller L.B., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003, 163:2066-2072.
23. Ammerlaan H., Seifert H., Harbarth S., Brun-Buisson C., Torres A., Antonelli M., et al. European Practices of Infections. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis 2009, 49:997-1005.
24. Vogelaers D., De Bels D., Forêt F., Cran S., Gilbert E., Schoonheydt K., et al. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates - a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents 2010, 35:375-381.
25. Cosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
26. Harbarth S., Rutschmann O., Sudre P., Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998, 158:182-189.
27. Troidle L., Eisen T., Pacelli L., Finkelstein F. Complications associated with the development of bacteremia with Staphylococcus aureus. Hemodial Int 2007, 11:72-75.
28. Fowler V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012-3021.
29. Jensen A.G., Espersen F., Skinhøj P., Rosdahl V.T., Frimodt-Møller N. Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect 1997, 34:113-118.
30. Stryjewski M.E., Szczech L.A., Benjamin D.K., Inrig J.K., Kanafani Z.A., Engemann J.J., et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007, 44:190-196.
31. Kim S.H., Kim K.H., Kim H.B., Kim N.J., Kim E.C., Oh M.D., et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008, 52:192-197.